V507 Assessment: anemia
Written V0507 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.80(a) Standard: Assessment criteria. The patient’s comprehensive assessment must include, but is not limited to, the following: (4) Evaluation of factors associated with anemia, such as hematocrit, hemoglobin, iron stores, and potential treatment plans for anemia, including administration of erythropoiesis-stimulating agent(s).
CMS's interpretive guidance
Interpretive Guidance §494.80(a)(4)
Each patient’s hematologic status must be evaluated for determination of their individual anemia management needs.
Evaluation should address the patient’s anemia, including an assessment of the need for erythropoiesis-stimulating agents (ESA) and/or iron therapy. Evaluation should also address the patient’s volume status, potential for bleeding, infection and other causes of hypo-response.
Citation should not be based solely on the patient’s clinical laboratory results for anemia. Any deficiency for anemia management must be supported by the facility’s lack of identification and assessment of the patient’s hematologic status and/or failure to develop or implement an appropriate plan to help meet the patient’s hematologic needs.
Requirements for the plan of care for anemia management are at V547.
Connected tags
Tags whose guidance points here
https://middlemolecule.com/rulebook/tags/v507/